Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Will Trump give pharma a gift? Fines for overcharging safety-net hospitals may be delayed

  • Ed Silverman

By Ed Silverman Aug. 30, 2017

Reprints
Pharmacy robot
Fred DuFour/AFP/Getty Images

The Trump administration may hand the pharmaceutical industry a gift, at least temporarily.

A controversial rule that would penalize drug makers for overcharging hospitals, clinics, and other providers for medicines that are purchased under the federal government’s 340B drug discount program may be delayed by nearly an entire year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
New weight loss drugs are changing the narrative on…
New weight loss drugs are changing the narrative on obesity, with a push from pharma
The fungal crisis is here and desperately needs addressing
The fungal crisis is here and desperately needs addressing
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO
Pharmalittle: Ohio attorney general accuses PBMs of price fixing;…
Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price…
With new study data, Intra-Cellular could expand use of…
With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

Recommended Stories